These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2694657)

  • 1. [Functional upper abdominal pain in Campylobacter-associated gastritis: does the patient profit from bismuth therapy?].
    Koop H
    Z Gastroenterol; 1989 Nov; 27(11):701-2. PubMed ID: 2694657
    [No Abstract]   [Full Text] [Related]  

  • 2. [Search for the best procedure for Campylobacter eradication. Results of long-term studies are still unavailable].
    Börsch G
    Fortschr Med; 1989 Jul; 107(22):471-2. PubMed ID: 2793022
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
    Rühl GH; Börsch G
    Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
    [No Abstract]   [Full Text] [Related]  

  • 4. [Helicobacter pylori eradication therapy with bismuth citrate/amoxycillin combination therapy].
    Stanescu A; Mayer D; Gabard B; Jost G; Baczako K; Dragici A; Malfertheiner P
    Leber Magen Darm; 1996 Jan; 26(1):32-6. PubMed ID: 8851875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.
    Loffeld RJ; Potters HV; Stobberingh E; Flendrig JA; van Spreeuwel JP; Arends JW
    Gut; 1989 Sep; 30(9):1206-12. PubMed ID: 2680795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
    Menge H; Hofmann J; Gregor M
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of Campylobacter-associated gastritis.
    McNulty CA
    Am J Gastroenterol; 1987 Mar; 82(3):245-7. PubMed ID: 3493685
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo susceptibility of Campylobacter pylori.
    Graham DY; Klein PD; Opekun AR; Smith KE; Polasani RR; Evans DJ; Evans DG; Alpert LC; Michaletz PA; Yoshimura HH
    Am J Gastroenterol; 1989 Mar; 84(3):233-8. PubMed ID: 2919580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.
    Marshall BJ; Warren JR; Francis GJ; Langton SR; Goodwin CS; Blincow ED
    Am J Gastroenterol; 1987 Mar; 82(3):200-10. PubMed ID: 3548326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of Helicobacter pilori: reasons to believe it].
    Amouretti M
    Rev Prat; 1990 Feb; 40(4):339-40. PubMed ID: 2305196
    [No Abstract]   [Full Text] [Related]  

  • 13. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Campylobacter pylori associated gastritis].
    Internist (Berl); 1989 Dec; 30(12):830-2. PubMed ID: 2621061
    [No Abstract]   [Full Text] [Related]  

  • 17. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined drug therapy against Campylobacter in duodenal ulcer and non-ulcerous dyspepsia].
    Tyszkiewicz T
    Lakartidningen; 1989 Mar; 86(10):843. PubMed ID: 2921896
    [No Abstract]   [Full Text] [Related]  

  • 19. [Campylobacter pylori and therapy with bismuth salts].
    Börsch G
    Med Monatsschr Pharm; 1988 Sep; 11(9):301-7. PubMed ID: 3067064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy of Campylobacter pylori-associated gastritis].
    Bielefeldt K
    Dtsch Med Wochenschr; 1988 Sep; 113(38):1495-6. PubMed ID: 3168772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.